Synthesis Characterization And Pharmacological Evalution Of Novel 2,4-Thiazolidinedione Derivatives Using In Silico Approach

The development of novel therapeutic agents remains a central objective of pharmaceutical and medicinal chemistry research. Heterocyclic compounds, owing to their structural diversity and ability to interact with biological macromolecules, constitute a major proportion of clinically approved drugs. Among various heterocycles, 2,4-thiazolidinedione (2,4-TZD) has attracted significant attention as a privileged scaffold due to the presence of both sulfur and nitrogen atoms along with two carbonyl functionalities within a five-membered ring system. These structural features enable strong hydrogen bonding and electrostatic interactions with a variety of biological targets, thereby conferring broad pharmacological potential.

Thiazolidinedione derivatives gained considerable clinical importance with the discovery of antidiabetic agents such as pioglitazone and rosiglitazone, which function as agonists of peroxisome proliferator-activated receptor gamma (PPAR-γ). Activation of PPAR-γ improves insulin sensitivity, regulates glucose homeostasis, and modulates lipid metabolism, making TZDs effective in the management of type 2 diabetes mellitus. Despite their therapeutic efficacy, the clinical use of conventional TZDs has been associated with adverse effects including weight gain, fluid retention, and increased cardiovascular risk. These limitations have stimulated extensive research efforts toward the design of novel TZD derivatives with enhanced therapeutic benefits and improved safety profiles.  

Structural modification of the TZD nucleus is a widely adopted strategy to optimize biological activity. Substitution at the 3- and 5-positions of the thiazolidinedione ring has been shown to play a crucial role in determining pharmacological behavior. Incorporation of aromatic moieties derived from substituted anilines such as aniline, 4-fluoroaniline, o-chloroaniline, and p-chloroaniline introduces electronic and steric variations that can significantly influence receptor binding, metabolic stability, and lipophilicity. Furthermore, conjugation of the TZD core with aromatic aldehydes such as p-hydroxybenzaldehyde via Knoevenagel condensation reactions at the C-5 position has been reported to enhance antimicrobial, anti-inflammatory, and anticancer activities.

The synthesis of 2,4-thiazolidinedione derivatives generally involves accessible and cost-effective reagents, including monochloroacetic acid, thiourea, chloroacetyl chloride, and suitable bases and solvents. These reagents facilitate efficient cyclization and functionalization reactions, enabling the generation of structurally diverse TZD analogues. Comprehensive characterization using analytical techniques such as infrared spectroscopy, nuclear magnetic resonance spectroscopy, and mass spectrometry is essential to confirm chemical structure, functional group integrity, and purity of the synthesized compounds.In recent years, the integration of in silico approaches with conventional synthetic methodologies has significantly transformed the drug discovery process. Computational tools such as molecular docking, quantitative structure–activity relationship (QSAR) analysis, ADMET prediction, and molecular dynamics simulations allow rapid screening of large compound libraries, prediction of binding interactions with biological targets, and early assessment of pharmacokinetic and toxicity profiles. The use of these techniques reduces experimental cost and time while improving the success rate of lead identification and optimization. In this context, the present review provides a comprehensive overview of the synthesis, characterization, and pharmacological relevance of novel 2,4-thiazolidinedione derivatives prepared using substituted anilines and related reagents. Special emphasis is placed on the role of in silico approaches in guiding rational design and pharmacological evaluation of TZD derivatives, highlighting their potential as promising candidates for the development of safer and more effective therapeutic agents.

Fig : important of 2,4-Thiazolidione

The discovery and development of new drug molecules is a continuously evolving process driven by the increasing prevalence of chronic diseases and the limitations associated with existing therapies. Medicinal chemistry plays a vital role in this process by designing and synthesizing novel chemical entities with improved biological activity and safety. Heterocyclic compounds are of particular interest because of their structural versatility and frequent occurrence in bioactive molecules. Among these, 2,4-thiazolidinedione (2,4-TZD) has emerged as an important pharmacophore due to its unique chemical architecture and wide spectrum of therapeutic applications.

Fig: Rational synthesis and in silico evaluation approach

The 2,4-thiazolidinedione ring system comprises a five-membered heterocycle containing sulfur and nitrogen atoms, along with two carbonyl groups that impart strong electron-withdrawing properties. This configuration enhances the ability of TZD derivatives to form stable interactions with enzymes, receptors, and transcription factors. As a result, compounds based on the TZD scaffold have demonstrated significant pharmacological activities including antidiabetic, antiinflammatory, antimicrobial, antioxidant, and anticancer effects. The versatility of this scaffold has encouraged researchers to explore extensive structural modifications to expand its therapeutic potential beyond glucose regulation.

Chemical modification of the TZD nucleus is commonly achieved by introducing different substituents on the nitrogen atom and at the methylene position of the ring. Aromatic substitution using halogenated and unsubstituted anilines has proven particularly effective in modulating electronic properties, lipophilicity, and metabolic stability of TZD derivatives. Similarly, condensation reactions with substituted aromatic aldehydes generate benzylidene-TZD derivatives that often exhibit enhanced biological activity. The availability of simple and economical reagents such as monochloroacetic acid, thiourea, and chloroacetyl chloride allows flexible synthetic routes and facilitates the preparation of structurally diverse compounds for pharmacological screening. With the growing emphasis on efficiency in drug discovery, computational methods have become indispensable tools in modern pharmaceutical research. In silico techniques enable the virtual evaluation of compounds prior to synthesis or biological testing, thereby reducing cost and experimental complexity. Molecular docking studies provide insights into ligand–target interactions, while QSAR models help correlate chemical structure with biological response. Additionally, ADMET prediction tools assist in identifying potential pharmacokinetic and toxicity issues at an early stage, improving the likelihood of clinical success.

MATERIALS AND METHODS

Materials : 

Aniline, 4-fluoroaniline, o-chloroaniline, and p-chloroaniline were employed as aromatic amine sources. Chloroacetyl chloride, monochloroacetic acid, thiourea, sodium acetate, potassium carbonate, and concentrated hydrochloric acid were used as key reagents for intermediate formation and cyclization reactions. Glacial acetic acid, dimethyl formamide (DMF), toluene, chloroform, methanol, ethanol, acetone, and distilled water were used as solvents. Piperidine was used as a base catalyst for condensation reactions, while magnesium sulphate served as a drying agent.

Methods

1. Synthesis of 2,4-Thiazolidinedione Core : The 2,4-thiazolidinedione nucleus was synthesized by cyclization of monochloroacetic acid with thiourea. Monochloroacetic acid was reacted with thiourea under acidic conditions using concentrated hydrochloric acid. The reaction mixture was heated under reflux for a specified duration, followed by cooling and neutralization. The resulting solid was filtered, washed with distilled water, and recrystallized to obtain pure 2,4-thiazolidinedione.
2. Synthesis of Substituted Chloroacetamide Intermediates : Substituted anilines (aniline, 4-fluoroaniline, o-chloroaniline, and p-chloroaniline) were reacted with chloroacetyl chloride in the presence of sodium acetate and glacial acetic acid. The reaction was carried out with continuous stirring under controlled temperature conditions. The formed chloroacetamide intermediates were isolated by precipitation, filtered, washed, and dried.
3. Formation of Substituted TZD Derivatives : The synthesized 2,4-TZD core was subjected to further derivatization through Knoevenagel condensation with p-hydroxybenzaldehyde. The reaction was carried out in ethanol or methanol using piperidine as a catalyst. The reaction mixture was refluxed until completion, monitored by thin-layer chromatography (TLC). The final benzylidene-substituted TZD derivatives were obtained after cooling, filtration, and recrystallization.
4. Purification of Compounds : Crude products were purified by recrystallization using suitable solvents such as ethanol, methanol, or acetone. Organic layers, when required, were dried over anhydrous magnesium sulphate and concentrated to yield purified compounds.

Pharmacological Evaluation Of 2,4-Thiazolidinedione Derivatives

1. Antidiabetic Activity

2,4-Thiazolidinedione derivatives primarily exert antidiabetic activity by activating Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ).

Mechanism of Action:

1. • Enhances insulin sensitivity in peripheral tissues
   • Regulates glucose and lipid metabolism
   • Improves adiponectin secretion  Methods:
   • In-vitro PPAR-γ activation assays
   • Glucose uptake studies in adipocyte cell lines
   • In-vivo antidiabetic studies in streptozotocin-induced diabetic rat models
2. Anti-Inflammatory Activity

TZD derivatives exhibit anti-inflammatory activity through inhibition of inflammatory mediators.

Mechanism:

2. • Suppression of COX-2 enzyme
   • Reduction of TNF-α, IL-6, and prostaglandins
   • Inhibition of NF-κB signaling pathway Methods:
   • Carrageenan-induced paw edema model
   • Inhibition of nitric oxide production in macrophages
   • COX enzyme inhibition assays
3. Anticancer Activity

Several TZD derivatives demonstrate promising anticancer potential against various cancer cell lines.

Mechanism:

• • Induction of apoptosis
  • Cell cycle arrest (G0/G1 or G2/M phase)
  • Inhibition of PI3K/Akt and MAPK pathways

 Methods:

3. • MTT and SRB cytotoxicity assays
   • Apoptosis studies (Annexin-V staining)
   • Molecular target docking with kinases and PPAR-γ
4. Antimicrobial Activity

Structural modification enhances antibacterial and antifungal properties.

Mechanism:

• • Disruption of microbial cell membrane
  • Inhibition of essential bacterial enzymes

 Methods:

4. • Agar well diffusion method
   • Minimum Inhibitory Concentration (MIC) determination
   • Activity against E. coli, S. aureus, P. aeruginosa, and C. albicans
5. Antioxidant Activity

TZD derivatives possess free radical scavenging ability.

Mechanism:

• • Donation of hydrogen or electrons
  • Reduction of oxidative stress

Methods:

5. • DPPH radical scavenging assay
   • ABTS assay
   • Nitric oxide scavenging assay
6. Hepatoprotective Activity

Certain TZD analogs show hepatoprotective effects.

Mechanism:

• • Reduction of lipid peroxidation
  • Enhancement of antioxidant enzyme levels

Methods:

• • CCl?-induced hepatotoxicity model
  • Estimation of serum liver enzymes (SGOT, SGPT, ALP)

IN-SILICO APPROACHES IN TZD DRUG DESIGN : 

The integration of in-silico techniques in the design of 2,4-thiazolidinedione (TZD) derivatives has emerged as a powerful strategy to accelerate drug discovery. Computational methods assist in predicting biological activity, optimizing molecular structure, and reducing experimental cost and time.

1. Molecular Docking Studies

Molecular docking is widely employed to predict the binding orientation and affinity of TZD derivatives with target proteins.

 Targets

• • • Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ)
    • Cyclooxygenase-2 (COX-2)
    • Protein kinases (PI3K, Akt)
    • Cancer-related receptors Significance:
    • Identifies key ligand–receptor interactions
    • Predicts hydrogen bonding, hydrophobic interactions, and binding energy
    • Helps in ranking compounds before biological screening